News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Daily News Ambiguous Angina: Physicians’ Ability to Properly Identify Chest Pain Varies Widely Yael L. Maxwell August 18, 2016
News Daily News USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents Michael O'Riordan August 09, 2016
News Daily News Cardiology’s Wage Gap: Time to ‘Own the Problem and Fix It,’ Experts Say Shelley Wood July 12, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016
News Daily News Dying on the Weekend? Not So Fast, Say Two Studies Examining Hospital Care on Saturdays, Sundays Todd Neale May 12, 2016
News Daily News Not Going Viral: Social Media Fails to Boost Exposure to Circulation Articles in Study Shelley Wood May 04, 2016
News Conference News ACC 2016 Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices L.A. McKeown April 03, 2016
News Daily News Los Cuidados Subóptimos de Mujeres con EAC se asocian a una Mayor Mortalidad a Largo Plazo Caitlin E. Cox February 28, 2016
News Daily News Undisclosed Clinical Trial Results Across All Major Academic Medical Centers: “A Failed Moral Obligation” Michael O'Riordan February 17, 2016
News Conference News AHA 2015 Female Cardiologists Underpaid and Outnumbered, with Ramifications for Patients and Profession Shelley Wood November 09, 2015
News Features When Paths Diverge—and Converge: Manish and Sahil Parikh Make Their Mark as Brothers, Clinicians, and Educators Nicole Lou August 15, 2015
News Daily News BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival Yael L. Maxwell August 12, 2015
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015
News Daily News FDA Approves Heart Failure Drug That Comes With Survival Benefit Todd Neale July 13, 2015
News Industry News First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit June 09, 2015
News Industry News Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease June 05, 2015